Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 4,113 | 42,822 | 14,884 | 13,031 | 4,852 |
| Gross Profit | 4,113 | 42,822 | 14,884 | 13,031 | 4,852 |
| Operating Expenses | 52,204 | 52,492 | 66,699 | 83,871 | 53,854 |
| Operating Income | -48,091 | -9,670 | -51,815 | -70,840 | -49,002 |
| Other Income | 3,248 | 1,425 | 1,515 | 955 | 1,371 |
| Pre-tax Income | -44,843 | -8,245 | -50,300 | -69,885 | -47,631 |
| Net Income Continuous | -44,843 | -8,245 | -50,300 | -69,885 | -47,631 |
| Net Income | $-44,843 | $-8,245 | $-50,300 | $-69,885 | $-47,631 |
| EPS Basic Total Ops | -0.46 | -0.07 | -0.65 | -0.91 | -0.63 |
| EPS Basic Continuous Ops | -0.46 | -0.07 | -0.65 | -0.91 | -0.63 |
| EPS Diluted Total Ops | -0.46 | -0.07 | -0.65 | -0.91 | -0.63 |
| EPS Diluted Continuous Ops | -0.46 | -0.07 | -0.65 | -0.91 | -0.63 |
| EPS Diluted Before Non-Recurring Items | -0.46 | -0.07 | -0.45 | N/A | N/A |
| EBITDA(a) | $-41,944 | $-5,303 | $-49,816 | $-68,722 | $-46,854 |